تقرير
Choriocarcinoma Syndrome: A Rare Complication's Impact on Metastatic Germ Cell Tumor Outcomes.
العنوان: | Choriocarcinoma Syndrome: A Rare Complication's Impact on Metastatic Germ Cell Tumor Outcomes. |
---|---|
المؤلفون: | Herr S; Department of Medicine, Drexel University College of Medicine, Philadelphia, USA., Garabet R; Department of Medicine, Drexel University College of Medicine, Philadelphia, USA., Tseng L; Department of Pulmonary Medicine, Kaiser Permanente Northern California, Walnut Creek, USA., Harzstark AL; Department of Urologic Oncology, Kaiser Permanente Northern California, San Francisco, USA., Russin MP; Department of Oncology, Kaiser Permanente Northern California, Walnut Creek, USA. |
المصدر: | Cureus [Cureus] 2024 Apr 16; Vol. 16 (4), pp. e58388. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024). |
نوع المنشور: | Case Reports |
اللغة: | English |
بيانات الدورية: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Palo Alto, CA : Cureus, Inc. |
مستخلص: | Choriocarcinoma syndrome is a rare form of tumor lysis syndrome that predominantly occurs in patients with metastatic germ cell tumors, particularly those presenting with extensive lung metastases. We report a case of a previously healthy 37-year-old male who presented with a painless left-sided neck lump and nipples with an increased sensitivity to light touch. Workup revealed a significantly elevated beta-human chorionic gonadotropin, a testicular mass, and innumerable pulmonary metastases, suggesting metastatic non-seminomatous germ cell tumor. Following the initiation of chemotherapy with etoposide, ifosfamide, and cisplatin (VIP), the patient experienced a rapid decline in respiratory function, culminating in acute respiratory distress syndrome and subsequent death from respiratory failure six weeks after starting treatment. This case emphasizes the importance of early detection and intervention in managing non-seminomatous germ cell tumors and highlights the critical need for awareness of choriocarcinoma syndrome's risks, the challenges of treatment delays for fertility preservation, and the exploration of alternative therapeutic strategies to improve outcomes in this high-risk patient population. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Herr et al.) |
References: | J Clin Oncol. 2021 May 10;39(14):1563-1574. (PMID: 33822655) Front Endocrinol (Lausanne). 2019 Apr 12;10:218. (PMID: 31031704) CA Cancer J Clin. 2019 Jan;69(1):7-34. (PMID: 30620402) J Cancer Res Clin Oncol. 2018 Sep;144(9):1817-1823. (PMID: 29974210) Case Rep Oncol Med. 2019 Feb 24;2019:4092941. (PMID: 30918732) Front Oncol. 2022 Jun 17;12:911879. (PMID: 35795064) Support Care Cancer. 1994 Jul;2(4):253-8. (PMID: 8087445) Ann Oncol. 2010 Aug;21(8):1585-1588. (PMID: 20181575) Eur Urol. 2015 Dec;68(6):1054-68. (PMID: 26297604) |
فهرسة مساهمة: | Keywords: case report; choriocarcinoma; choriocarcinoma syndrome; germ cell tumor; tumor lysis syndrome |
تواريخ الأحداث: | Date Created: 20240517 Latest Revision: 20240518 |
رمز التحديث: | 20240518 |
مُعرف محوري في PubMed: | PMC11097919 |
DOI: | 10.7759/cureus.58388 |
PMID: | 38756265 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2168-8184 |
---|---|
DOI: | 10.7759/cureus.58388 |